These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 18382255)

  • 1. Biomarkers in acute cardiovascular disease.
    Howie-Esquivel J; White M
    J Cardiovasc Nurs; 2008; 23(2):124-31. PubMed ID: 18382255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Redefinition of myocardial infarction--relevance of biomarkers].
    Weber M; Hamm C
    Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of existing and novel cardiac biomarkers for cardioprotection.
    Gaze DC
    Curr Opin Investig Drugs; 2007 Sep; 8(9):711-7. PubMed ID: 17729182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of biochemical markers in diagnosis of myocardial infarction.
    Khan IA; Wattanasuwan N
    Int J Cardiol; 2005 Sep; 104(2):238-40. PubMed ID: 16168823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of cardiovascular damage and dysfunction--an overview.
    Collinson PO; Gaze DC
    Heart Lung Circ; 2007; 16 Suppl 3():S71-82. PubMed ID: 17618829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cardiac biomarkers in end-stage renal disease.
    Wang AY; Lai KN
    J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular biomarkers in the ICU.
    Noveanu M; Mebazaa A; Mueller C
    Curr Opin Crit Care; 2009 Oct; 15(5):377-83. PubMed ID: 19606027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of cardiovascular damage.
    Collinson PO; Gaze DC
    Med Princ Pract; 2007; 16(4):247-61. PubMed ID: 17541289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troponin assays for the diagnosis of myocardial infarction and acute coronary syndrome: where do we stand?
    Eisenman A
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):509-14. PubMed ID: 16918269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.
    Sommerer C; Giannitsis E; Schwenger V; Zeier M
    Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troponin: the biomarker of choice for the detection of cardiac injury.
    Babuin L; Jaffe AS
    CMAJ; 2005 Nov; 173(10):1191-202. PubMed ID: 16275971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical biomarkers of cardiac injury: cardiac troponins and natriuretic peptides.
    Apple FS
    Toxicol Pathol; 2006; 34(1):91-3. PubMed ID: 16507549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
    Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
    Palazzuoli A; Iovine F; Gallotta M; Nuti R
    Minerva Cardioangiol; 2007 Aug; 55(4):491-6. PubMed ID: 17653025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of cardiac troponins (T or I) measurement in cardiology and various clinical settings].
    Berroëta C; Provenchère S; Mongredien A; Lasocki S; Benessiano J; Dehoux M; Philip I
    Ann Fr Anesth Reanim; 2006 Oct; 25(10):1053-63. PubMed ID: 16019183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Troponin elevation--differential diagnostic considerations and prognostic importance].
    Jensen JK; Mickley H
    Ugeskr Laeger; 2003 Apr; 165(15):1541-5. PubMed ID: 12715654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of biomarkers in the emergency department and chest pain unit.
    Jaffe AS
    Cardiol Clin; 2005 Nov; 23(4):453-65, vi. PubMed ID: 16278117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac biomarkers in chronic renal disease.
    Collinson PO; Gaze DC
    Scand J Clin Lab Invest Suppl; 2008; 241():104-8. PubMed ID: 18569976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.